Pulmonary Hypertension Prevention in Hemodialysis

• Conditions: Chronic Kidney Disease

• Registration Number: NCT01350687
• Lead Sponsor: The Baruch Padeh Medical Center, Poriya

Brief Summary

Pulmonary hypertension is a new complication described in hemodialysis patients. in the last year these patients were treated by calcium carbonate orally to control serum phosphor. Calcium phosphor deposits in pulmonary artery can explain this phenomena. The investigators want to investigate the new phosphor non calcium containing agents in hemodialysis patients and to measure the pulmonary pressure.

Detailed Description

The investigators will measure pulmonary blood pressure before and after treatment with new phosphor binders, non calcium containing.

Study Timeline

• Status Verified: 2011-04
• Study First Submitted: 2011-05-08
• Study First Submitted QC: 2011-05-09
• Last Update Submitted: 2011-05-09
• Study First Posted: 2011-05-10
• Last Update Posted: 2011-05-10
• Study Start: 2011-06
• Primary Completion: 2013-06
• Study Completion: 2014-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Hemodialysis Patients without fistula

Exclusion Criteria

• Heart Disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Poria Medical Center; 🇮🇱 Tiberias, Israel